Cases 1 - 10 of 3,872
In Re: Aflibercept Patent Litigation
as 1:2024md03103
Not Yet Classified:
AFLIBERCEPT PATENT LITIGATION
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals, Inc., AMGEN USA, INC., BIOCON BIOLOGICS INC. and others
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
Bausch Health Ireland Limited et al v. Mylan Pharmaceuticals Inc.
as 1:2024cv00036
Plaintiff:
Bausch Health Ireland Limited and Salix Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AMERICAN AIRLINES, INC. et al v. ACTAVIS HOLDCO U.S., INC. et al
as 2:2024cv01430
Plaintiff:
AMERICAN AIRLINES, INC., ARAMARK SERVICES, INC., GENERAL MOTORS LLC and others
Defendant:
ACTAVIS HOLDCO U.S., INC., ACTAVIS ELIZABETH LLC, ACTAVIS PHARMA, INC. and others
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
Actelion Pharmaceuticals, Ltd. v. Mylan Pharmaceuticals Inc.
as 24-1641
Plaintiff:
ACTELION PHARMACEUTICALS, LTD.
Defendant:
MYLAN PHARMACEUTICALS INC.
CLEGHORN et al v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2024cv04427
Plaintiff:
ERIC CLEGHORN and HEATHER CLEGHORN
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., AUROBINDO PHARMA, LTD., HETERO DRUGS, LTD. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Personal Injury
WARFEL vs. CVS PHARMACY, INC. et al
as 1:2024cv04243
Plaintiff:
RANDY L. WARFEL
Defendant:
JOHN DOE II, CVS PHARMACY, INC., JOHN DOE and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
SNIPE et al v. MYLAN LABORATORIES LTD. et al
as 1:2024cv04013
Plaintiff:
JANET SNIPE and WILLIAM SNIPE
Defendant:
MYLAN LABORATORIES LTD., MYLAN N.V., MYLAN PHARMACEUTICALS INC. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Jefferson County v. Express Scripts, Inc., et al
as 24-1550
Plaintiff:
Jefferson County
Defendant:
M.D. Dannie E. Williams, Delmar Primary Care Associates, LLC, Gurpreet S. Padda and others
PRINCE v. AUROBINDO PHARMA, LTD. et al
as 1:2024cv02946
Plaintiff:
BRIAN PRINCE
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
as 24-1564
Appellant:
REGENERON PHARMACEUTICALS, INC.
Defendant / Appellee:
MYLAN PHARMACEUTICALS INC. and CELLTRION, INC.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
